These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9516971)

  • 1. Genetic changes and telomerase activity in human renal cell carcinoma.
    Rohde V; Sattler HP; Oehlenschläger B; Forster S; Zwergel T; Seitz G; Wullich B
    Clin Cancer Res; 1998 Jan; 4(1):197-202. PubMed ID: 9516971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in human renal cell carcinoma.
    Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
    Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hTERT expression in sporadic renal cell carcinomas.
    Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
    J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue.
    Rohde V; Sattler HP; Bund T; Bonkhoff H; Fixemer T; Bachmann C; Lensch R; Unteregger G; Stoeckle M; Wullich B
    Clin Cancer Res; 2000 Dec; 6(12):4803-9. PubMed ID: 11156238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.
    Izumi H; Hara T; Oga A; Matsuda K; Sato Y; Naito K; Sasaki K
    Neoplasia; 2002; 4(2):103-11. PubMed ID: 11896565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere shortening in renal cell carcinoma.
    Mehle C; Ljungberg B; Roos G
    Cancer Res; 1994 Jan; 54(1):236-41. PubMed ID: 8261445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.
    Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL
    Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic, flow cytometric, and ultrastructural studies of twenty-nine nonfamilial human renal carcinomas.
    Wolman SR; Camuto PM; Golimbu M; Schinella R
    Cancer Res; 1988 May; 48(10):2890-7. PubMed ID: 3359446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
    Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
    Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
    Jones TD; Eble JN; Wang M; Maclennan GT; Jain S; Cheng L
    Cancer; 2005 Sep; 104(6):1195-203. PubMed ID: 16047350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis.
    Jong HS; Park YI; Kim S; Sohn JH; Kang SH; Song SH; Bang YJ; Kim NK
    Cancer; 1999 Aug; 86(4):559-65. PubMed ID: 10440682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
    Bednarek AK; Sahin A; Brenner AJ; Johnston DA; Aldaz CM
    Clin Cancer Res; 1997 Jan; 3(1):11-6. PubMed ID: 9815531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity in human bladder cancer.
    Lin Y; Miyamoto H; Fujinami K; Uemura H; Hosaka M; Iwasaki Y; Kubota Y
    Clin Cancer Res; 1996 Jun; 2(6):929-32. PubMed ID: 9816252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing genetic heterogeneity of renal cell tumors.
    Mirghomizadeh F; Kupka S; Blin N
    Anticancer Res; 1999; 19(2C):1467-70. PubMed ID: 10365125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
    He GP; Shui QL; Huang Y; Zhang SZ; Yu H
    Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.